Guilford And Gliatech To Merge

Inc. and Inc. have entered into a definitive merger agreement pursuant to which Guilford will acquire all of the outstanding common stock of Gliatech.

The transaction combines the capabilities of both companies in biopolymer development and the development of novel drugs for the treatment of central nervous system disorders.

The combined company will have three marketed products and nine product candidates in clinical development.

Craig R. Smith, MD, President and CEO of Guilford commented, “The strategic combination of our two companies will allow us to realize greater competitive advantages, achieve operational synergies and efficiencies, provide greater access to capital and create greater critical mass with which to pursue our corporate objectives.

Together, we have an excellent commercial platform with three marketed biopolymer products for the surgical marketplace and a broad and well-diversified pipeline of product candidates at every stage of clinical development.”

The combined company will consolidate its corporate and research operations in Baltimore, while maintaining a manufacturing facility in Solon, Ohio.

Dr. Smith will retain his position as President and CEO and Thomas O. Oesterling, Ph.D., Chairman and CEO of Gliatech, will join the Board of Directors and the management team and lead strategic planning activities for the Company.

“We are delighted to join forces with Guilford in building a first-class biopharmaceutical company,” commented Dr. Oesterling.

“It quickly became apparent as we entered negotiations that the strategic fit was excellent, both in terms of corporate structure and technology platform.

As a combined entity, we are in a position to build a strong commercial enterprise with the ability to increase product-related revenues and nurture a strong development pipeline.” The combined company also has several neurological programs in its research pipeline.

Its PARP and serine racemase programs aim to inhibit cell damage and death in acute and chronic neurodegenerative disorders including stroke, spinal cord trauma, Parkinson’s disease and inflammation.

The combined company is also developing compounds based on the activity of inflammation-producing glial cells to slow or inhibit the progression of ’s disease; H3 agonists for the treatment of anxiety and insomnia; inhibitors of glycine transporters for potential treatment in schizophrenia, and a monoclonal antibody that may be useful in inflammatory diseases.

Dragon Pharma LLC Ready for Use

Propionat 100 - Discount Price

Administration: Injection
Base Substance: Testosterone Propionate
Made by: Dragon Pharmaceutical
Unit: 30 x 10 mL vial (100 mg/mL)
Price: 30 x $20.00

Propionat 100 - Bulk Price

Administration: Injection
Basic Substance: Testosterone Propionate
Produced by: Dragon Pharmaceutical
Pack: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $30.00

Cypionat 250 - Discount Price

Administration: Injection
Primary Ingredient: Testosterone Cypionate
Producer: Dragon Pharmaceuticals
Package: 30 x 10 mL vial (250 mg/mL)
Price: 30 x $25.00

Turanabol - Bulk Price

Administration: Oral
Basal Substance: Chlorodehydromethyltestosterone
Producer: Dragon Pharma
Pack: 10 x 100 tablets (10 mg/pastille)
Price: 10 x $70.00

Trenbolone 50

Injectable Anabolic Steroid
Main Ingredient: Trenbolone Suspension
Produced by: Dragon Pharma
Unit: 1 X 10 mL vial (50 mg/mL)

Winstrol Tabs - Bulk Price

Administration: Oral
Basal Chemical Name: Stanozolol
Manufacturer: Dragon Pharmaceuticals
Amount: 10 x 100 tabs (50 mg/tablet)
Price: 10 x $63.00

Turanabol - Cheap Price

Administration: Oral
Basic Substance: Chlorodehydromethyltestosterone
Produced by: Dragon Pharma Labs
Unit: 20 x 100 tablets (10 mg/pill)
Price: 20 x $60.00

Propionat 100

Injectable Anabolic Steroid
Active Substance: Testosterone Propionate
Made by: Dragon Pharma
Unit: 1 X 10 ml (100 mg/ml)

Dianabol

Natural Anabolic Steroidal Agent
Basic Constituent: Methandrostenolone
Branded by: Dragon Pharma LLC
Pack: 1 X 100 tablets (20 mg/pill)

Trenbolone 100 [10 Vials]

Injectable Steroid for Muscle Growth
Basic Chemical Name: Trenbolone Acetate
Branded by: Dragon Pharma LLC
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $60.00 = $600.00 in Total

Deca 300

Injectable Steroid for Muscle Growth
Base Ingredient: Nandrolone Decanoate
Manufacturer: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (300 mg/mL)

Parabolan 100

Injectable Steroid for Muscle Growth
Prime Component: Trenbolone Hexahydrobenzylcarbonate
Produced by: Dragon Pharmaceutical
10 mL Sterile Multi-dose Vial (100 mg/mL)